Skip to content

News and Events

Upcoming Education Opportunities

Project ECHO

ECTRIMS

ACTRIMS

Latest Updates

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis

In this study the Authors developed a Therapeutic Escalation Score (TES) to identify children at low…

Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis

Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis

In this recent study, prior adenotonsillectomy was associated with increased risk of MS and greater …

FDA APPROVES OCREVUS FOR PEDIATRIC MS

FDA APPROVES OCREVUS FOR PEDIATRIC MS

FDA approves Ocrevus for relapsing-remitting MS in pediatric patients 10 years of age and older In t…

Role of tocilizumab in severe CNS inflammatory presentations in children

Role of tocilizumab in severe CNS inflammatory presentations in children

In this study, eleven patients were included, of whom 8 demonstrated clinical improvement within 72 …

Factors influencing early and late B-cell repopulation after Rituximab therapy in pediatric CNS inflammatory disorders

Factors influencing early and late B-cell repopulation after Rituximab therapy in pediatric CNS inflammatory disorders

This study showed that age and the number of infusions influence the timing of B-cell repopulation. …

Higher ultra-processed food consumption is associated with higher likelihood of pediatric-onset multiple sclerosis

Higher ultra-processed food consumption is associated with higher likelihood of pediatric-onset multiple sclerosis

In this study participants with pediatric-onset MS reported greater consumption of ultra-processed f…

Upcoming Events